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Phytoestrogen has been proposed as an alternative to hormone replacement therapy,
which has been demonstrated to promote a high risk of breast cancer. However, the
effect of phytoestrogen on breast cancer development has not been fully understood.
Bakuchiol is an active ingredient of a traditional Chinese herbal medicine Fructus
Psoraleae, the dried ripe fruit of Psoralea corylifolia L. (Fabaceae). The in vitro and in vivo
estrogenic activities and anti-breast cancer effects of bakuchiol have not been well-
studied. We found that bakuchiol induced the GFP expression in transgenic medaka
(Oryzias melastigma, Tg, Chg:GFP) dose-dependently (0–1 µg/ml), demonstrating its
in vivo estrogenic activity. Low dose of bakuchiol (1 µg/ml) induced the cell proliferation
and ERα expression in MCF-7 cells, which could be blocked by the anti-estrogen ICI
182780, suggesting the in vitro estrogenic activity of bakuchiol. Our data indicated
that high doses of bakuchiol (>2 µg/ml) inhibited breast cancer cell growth, with a
stronger anti-proliferative effect than resveratrol, a widely studied analog of bakuchiol.
High doses of bakuchiol (4, 7, and 10 µg/ml) were used for the further in vitro anti-breast
cancer studies. Bakuchiol induced ERβ expression and suppressed ERα expression in
MCF-7 cells. It also induced S phase arrest in both MCF-7 and MDA-MB-231 cells,
which could be rescued by caffeine. Knock-down of p21 also marginally rescued S
phase arrest in MCF-7 cells. The S phase arrest was accompanied by the upregulation
of ATM, P-Cdc2 (Tyr15), Myt1, P-Wee1 (Ser642), p21 and Cyclin B1, suggesting that
blocking of Cdc2 activation may play an important role in bakuchiol-induced S phase
arrest. Furthermore, bakuchiol induced cell apoptosis and disturbed mitochondrial
membrane potential in MCF-7 cells. The bakuchiol-induced apoptosis was associated
with increased expression of Caspase family and Bcl-2 family proteins, suggesting
that bakuchiol may induce apoptosis via intrinsic apoptotic pathway. The in vivo anti-
breast cancer effect of bakuchiol was further proved in zebrafish (Danio rerio, wild-type
AB) xenografts. 0.5 µg/ml of bakuchiol significantly reduced the MCF-7 cell mass in
zebrafish xenografts. Overall, these results suggested the potential of using bakuchiol in
HRT and breast cancer treatment.
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INTRODUCTION
According to the statistics released by the International Agency
for Research on Cancer (2013)1, 1.7 million women were
diagnosed with breast cancer, which killed more than 0.5 million
women in 2012. The incidence rate and mortality had been
increased by 20 and 14% respectively since 2008 to 2012. Breast
cancer incidence in developed countries of North America and
Western Europe is historically higher than in Asian countries,
which has been associated to the higher intake of phytoestrogens
in the eastern continent (de Kleijn et al., 2001).
Phytoestrogens are a group of plant-derived substances, with
an estradiol-like structure or function. The main phytoestrogen
groups are lignans, flavonoids, coumestans, and stilbenes. Interest
in phytoestrogen has also increased as a result of the concerns
about HRT. HRT is widely used to relieve the menopausal
symptoms of post-menopausal women. However, it has been
demonstrated that estrogen, which is used in HRT, increases
the risk of breast cancer development (Key et al., 2001). Thus,
women, mainly those with a history of breast cancer, are turning
to the use of phytoestrogens, in the belief that they protect them
from breast cancer and they are safer than estrogen itself.
Selective estrogen receptor modulators are compounds that
selectively interact with ER either as ER agonists or antagonists
in different organs. They have been studied in the past decade
to treat hormone responsive cancer and menopausal symptoms.
Phytoestrogens have been proposed as natural SERMs (Oseni
et al., 2008). Lignans are the most major phytoestrogens found
in many fiber-rich foods such as cereal brans, fruits and
vegetables. They possess weak estrogenic or anti-estrogenic
activities (Pianjing et al., 2011). Soy isoflavones, such as genistein
and daidzein, are the most widely studied phytoestrogens.
These isoflavones have varying estrogenic and anti-carcinogenic
activities, and they have been proposed as natural SERMs
(Setchell, 2001). There are also many studies on coumestans.
Coumestans are found in various beans, alfalfa, and clover
sprouts. Many of their biological effects can be attributed to
their activation of ER signaling pathway, and the anti-cancer
effects of these compounds have been also described in the
last decade (Nehybová et al., 2014). Resveratrol, found naturally
in grapes and red wine, is the most common stilbene. It has
gained considerable attention because of its chemopreventive,
anti-oxidative, and anti-inflammatory properties (Patisaul and
Jefferson, 2010). Although, there are many in vitro and in vivo
data on the role of phytoestrogens in breast cancer treatment, the
data needs further research.
Bakuchiol is a meroterpene, which can be found in the
traditional Chinese herbal medicine Fructus Psoraleae, the dried
Abbreviations: Chg, choriogenin; DMEM, Dulbecco’s modified Eagle medium;
DMSO, dimethyl sulfoxide; dph, days of post-hatching; E2, 17β-estradiol;
EC50, effective concentration 50; ER, estrogen receptor; FBS, fetal bovine
serum; GFP, green fluorescent protein; hpf, hours of post-fertilization; HRT,
hormone replacement therapy; LC50, lethal concentration 50; PBS, phosphate-
buffered saline; PI, propidium iodide; PMSF, phenylmethylsulfonyl fluoride; PTU,
phenythiourea; RIPA buffer, radio-immunoprecipitation assay buffer; SERM,
selective estrogen receptor modulator.
1http://www.iarc.fr/en/media-centre/pr/2013/pdfs/pr223_E.pdf
ripe fruit of Psoralea corylifolia L. (Fabaceae). It is shown
to have anti-microbial, anti-inflammatory, anti-oxidative, anti-
osteoporosis, and anti-depression or anti-stress activities (Lim
et al., 2009; Choi et al., 2010; Kim et al., 2013; Huang et al.,
2014; Mao et al., 2014). The estrogenic activities of bakuchiol
were reported in several in vitro models (Xin et al., 2010; Lim
et al., 2011; Mao et al., 2014). However, whether bakuchiol
displays estrogenic activity in in vivo model is rarely studied
(Shou et al., 2007; Lim et al., 2009). We developed transgenic
medaka (Oryzias melastigma, Tg, Chg:GFP), in which the liver-
specific and estrogen-sensitive choriogenin gene promoter drives
GFP expression, in a previous study (Chen et al., 2007). With
this transgenic fish, we could screen estrogenic activity of
bakuchiol in vivo. The anti-cancer potential of bakuchiol has
been reported in very few studies. Bakuchiol inhibits liver
cancer cell growth through inducing S phase arrest, caspase
9/3 activaton, p53 and Bax up-regulation, as well as Bcl-2
down-regulation (Chen Z. et al., 2010). It also inhibits human
carboxylesterase 2, which is commonly expressed in tumor
tissue and involved in the metabolism of endogenous lipids
and drugs (Li et al., 2015). To date, limited studies have
demonstrated the effect of bakuchiol on breast cancer cell growth
(Chen H.L. et al., 2010; Xin et al., 2010). However, the anti-
cancer effect of resveratrol, an analog of bakuchiol, has been
extensively reported (Bernhard et al., 2000; Joe et al., 2002;
Tyagi et al., 2005; Chen et al., 2013). The mechanisms of
the anti-cancer effects of resveratrol, including promoting cell
cycle arrest, inducing apoptosis, preventing tumor-derived nitric
oxide synthase expression, inhibiting cyclooxygenase activity,
and decreasing DNA binding activity of nuclear factor κB, have
been well-summarized in a previous review (Carter et al., 2014).
However, the mechanisms of how bakuchiol affects breast cancer
cell growth and the in vivo anti-breast cancer effects of bakuchiol
have not been investigated. It is important to investigate the
estrogenic and anti-breast cancer activities of bakuchiol both
in vitro and in vivo, and to reveal the underlying mechanisms of
these effects.
MATERIALS AND METHODS
Chemicals and Reagents
Bakuchiol {4-[(1E,3S)-3-ethenyl-3,7-dimethylocta-1,6-dienyl]
phenol} (Figure 1) purity 98% by HPLC, was obtained from
FIGURE 1 | Structure of bakuchiol.
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Enzo (Farmingdale, NY, USA). Resveratrol, 17β-estradiol (E2),
and PTU was purchased from Sigma (St. Louis, MO, USA).
ICI 182780 was bought from Abcam (Cambridge, MA, USA).
DMEM, FBS, penicillin, streptomycin, PI, JC-1 dye, TRIzol
reagent and PBS were purchased from Invitrogen (Carlsbad, CA,
USA). FuGENE 6 transfection reagent, MTT, DMSO, caffeine,
RNase A, annexin V-FITC/PI apoptosis kit, RQ1 RNase-free
DNase, RIPA buffer, PMSF and Na2CO3 were bought from
Promega (Madison, WI, USA). Kapa SYBR FAST qPCR kit was
obtained from Kapa Biosystems (Wilmington, MA, USA), and
high capacity RNA-to-cDNA master mix came from Applied
Biosystems (Carlsbad, CA, USA). ECL Prime Western blotting
detection system was obtained from GE Healthcare (Milwaukee,
WI, USA). All antibodies were purchased from Cell Signaling
Technology (Danvers, MA, USA).
Medaka Fish Exposure
Larvae within 2 days dph were used for exposure. Twenty larvae
were exposed in a 50 mm glass Petri dish for 24 h. Triplicates were
carried out for each concentration and for the solvent control.
After exposure, the fish were deposited onto the inner side of
Petri dish cover with little water left. The induced GFP expression
in the liver was observed under stereomicroscope (model M205
FA, Leica Microsystems, Germany). The images were recorded
with the same parameter settings for the same set of exposed
samples. Fluorescence intensity was quantified by image analysis
software, Metamorph 5.0 (Universal Imaging, Downingtown, PA,
USA). To reduce the interference of fish auto-fluorescence, only
the fish liver was selected for analysis. The average fluorescence
of the liver area was regarded as the GFP signal intensity. All
procedures with fish were conducted following the License to
Conduct Experiments approved by the Government of the Hong
Kong SAR Department of Health [Ref. (21) in DH/HA&P/8/1/1
Pt.3].
Cell Culture
Two breast cancer cell lines were used in this study. MCF-
7 (ATCC: HTB-22) and MDA-MB-231 (ATCC: HTB-26) were
purchased from American Type Culture Collection (ATCC,
Manassas, VA, USA), The cell lines were routinely maintained in
DMEM supplemented with 10% FBS, 0.37% Na2CO3, 50 units/ml
penicillin and 50 µg/ml streptomycin, incubated at 37◦C in a
humidified atmosphere with 5% CO2.
RNA Interference
Cells were seeded in 6-well plate and T25 flask, and allowed to
attach before transfection. Cells were transfected with 25 nM
siRNA (Ambion, Austin, TX, USA) with FuGENE 6 transfection
reagent following the manufacturer’s recommendations. After
transfection for 24 h, medium was changed and cells were
incubated for 24 h before collected for following experiment.
Cell Growth Inhibition Study Using MTT
Assay
Cells were seeded at 5000 cells/well into 96-well plates. For the
experiment in Figure 3A, MCF-7 and MDA-MB-231 cells were
treated with serial concentrations of bakuchiol for 24, 48, and
72 h. For the experiment in Figure 3B, MCF-7 and MDA-MB-
231 cells were treated with serial concentrations of resveratrol
for 24, 48, and 72 h. For the experiment in Figure 3C, MCF-7
cells were treated with ethanol alone or 1µg/ml bakuchiol and/or
1 µM ICI 182780 for 72 h. For the experiment in Figure 6A,
MCF-7 cells were transfected with siCtrl or sip21, and treated
with 0 or 7 µg/ml of bakuchiol for 24 h. After treatment, the
cells were washed with PBS and incubated with 0.5% MTT for
3 h. DMSO was used to dissolve the formazan crystals, and the
optical density of 570 nm of each well was obtained by a multi-
well scanning spectrophotometer (Model 550, Bio-Rad, Hercules,
CA, USA).
Cell Cycle Analysis Using PI Staining
For the experiment in Figure 4A, MCF-7 cells and MDA-MB-
231 cells were treated with varying concentrations of bakuchiol
for 24 h. For the experiment in Figure 5A, MCF-7 cells and
MDA-MB-231 cells were treated with ethanol alone or 7µg/ml of
bakuchiol and/or 5 mM of caffeine for 24 h. For the experiment in
Figure 6B, MCF-7 cells were transfected with siCtrl or sip21, and
treated with 0 or 7 µg/ml of bakuchiol for 24 h. After treatment,
cells were trypsinized, washed with ice-cold PBS, and fixed with
70% ethanol at 4◦C overnight. For staining, the fixed cells were
centrifuged to remove ethanol and washed with PBS. Then the
cell pellets were resuspended with 50 µg/ml PI and 100 µg/ml
RNase A. After 30 min of incubation at 37◦C, the stained cell
suspension was analyzed by using a flow cytometer (Becton
Dickinson, San Diego, CA, USA) with an excitation wavelength
of 488 nm. The cell cycle distribution was calculated by using
MODFIT 3.0 software (Verity Software House, Topsham, ME,
USA).
Examination of Bakuchiol-Induced
Apoptosis with Annexin V/PI Staining
For the experiment in Figure 7B, MCF-7 cells were treated with
0–10 µg/ml of bakuchiol for 24 h. The analysis of apoptosis was
conducted using annexin V-FITC/PI apoptosis kit in accordance
with the manufacturer’s protocol.
Measurement of Mitochondrial
Membrane Potential with JC-1 Staining
For the experiment in Figure 7C, MCF-7 cells were treated with
0–10 µg/ml of bakuchiol for 24 h. Changes in mitochondrial
membrane potential were measured by using a flow cytometer
with JC-1 dye in accordance with the instructions of the
manufacturer.
RNA Extraction, Reverse Transcription,
and Quantitative Real-Time PCR
For the experiment in Figure 2E, medaka fish (n = 10) were
exposed to 0.5 µg/ml bakuchiol for 24 h. For the experiment
in Figure 3C, MCF-7 cells were treated with ethanol alone or
1 µg/ml bakuchiol and/or 1 µM ICI 182780 for 72 h. For the
experiment in Figure 3D, MCF-7 cells were treated with 0, 4, or
7 µg/ml of bakuchiol for 24 h. For the experiment in Figure 4C,
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FIGURE 2 | Screening of in vivo estrogenic activity with transgenic medaka. (A) Bakuchiol induced GFP expression in liver, the white bar indicates 100 µm.
(B) LC50 and EC50 of fish after exposure to bakuchiol for 24 h. Correlation between different concentrations of (C) bakuchiol and (D) E2, and the induced GFP signal
intensity. (E) Analysis of mRNA expression of ERα and ERβ by using real-time PCR. Fish (n = 10) were exposed to 0.5 µg/ml bakuchiol for 24 h. 18S rRNA was used
as the internal reference. BAK, bakuchiol.
MCF-7 cells and MDA-MB-231 cells were treated with ethanol
or 7 µg/ml of bakuchiol for 24 h. After the treatment, total
RNA of the fish larvae and breast cancer cells was extracted by
using the TRIzol reagent in accordance with the manufacturer’s
instructions. Total RNA sample was treated with RQ1 RNase-
free DNase to decontaminate the genomic DNA, and cDNA
was obtained from total RNA by using high capacity RNA-
to-cDNA master mix. Real-time PCR was performed with the
StepOnePlusTM Real-Time PCR System (Applied Biosystems,
Carlsbad, CA, USA), by using the Kapa SYBR FAST qPCR kit, and
following the recommendations of the manufacturer. Primers
were listed in Table 1.
Cell Protein Extraction and Western Blot
Analysis
For the experiment in Figure 4B, MCF-7 cells and MDA-MB-
231 cells were treated with varying concentrations of bakuchiol
for 24 h. For the experiment in Figure 5B, MCF-7 cells and
MDA-MB-231 cells were treated with ethanol alone or 7µg/ml of
bakuchiol and/or 5 mM of caffeine for 24 h. For the experiment
in Figure 6D, MCF-7 cells were transfected with siCtrl or sip21,
and treated with 0 or 7 µg/ml of bakuchiol for 24 h. For the
experiment in Figures 7D,E, MCF-7 cells were treated with
0–10 µg/ml of bakuchiol for 24 h. After treatment, the cells
TABLE 1 | Primers for quantitative real-time PCR.
Gene Forward (5′–3′) Reverse (5′–3′)
Fish 18S rRNA CCTGCGGCTTAATTGACCC GACAAATCGCTCCACCAACT
ERα ATTTGGAGGTCCATCCACTG TGAGTTTGAGCACACGGAAG
ERβ AGGAGCATCCAAGGACACAC GCCGACTTCGTAGCACTTTC
Cell GAPDH TCCCTGAGCTGAACGGGAAG GGAGGAGTGGGTG TCGCTGT
ERα AGCTCCTCCTCATCCTCTCC TCTCCAGCAGCAGGTCATAG
ERβ CCTCAAAAGAGTCCCTGGTG CTTCACACGACCAGACTCCA
p21 GAGGCCGGGATGAGTTGGGAGGAG CAGCCGGCGTTTGGAGTGGTAGAA
p53 CCCCTCCTGGCCCCTGTCATCTTC GCAGCGCCTCACAACCTCCGTCAT
ATM CCCCTTGTGTATGAGCAGGTG CGGATTATCCTGAGAAGCTC
ATR ACATTCCCTGATCCTACATCATG TTCAATAGATAACGGCAGTCCTG
Frontiers in Pharmacology | www.frontiersin.org 4 May 2016 | Volume 7 | Article 128
fphar-07-00128 May 21, 2016 Time: 13:40 # 5
Li et al. Phytoestrogen Bakuchiol Inhibits Breast Cancer
FIGURE 3 | Effects of bakuchiol on cell viability of breast cancer cells. MCF-7 and MDA-MB-231 cells were treated with serial concentrations of (A) bakuchiol
and (B) resveratrol for 24, 48 and 72 h, and cell proliferation was monitored by using MTT assay. The data were expressed as fold change of viability compared to
the vehicle control (ethanol) with standard deviation. (C) Fold changes of cell viability and ERα mRNA levels of MCF-7 cells, which were treated with ethanol alone or
1 µg/ml bakuchiol and/or 1 µM ICI 182780 for 72 h (compared with control group, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, one-way ANOVA). (D) ERα and ERβ
mRNA levels of MCF-7 cells, which were treated with 0, 4, or 7 µg/ml of bakuchiol for 24 h (compared with control group,∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001,
one-way ANOVA). BAK, bakuchol; RES, resveratrol; ICI, ICI 182780; Ctrl, control.
were collected and washed twice with ice-cold PBS. Cell pellets
were lysed with ice-cold RIPA buffer, which contained 1 mM
PMSF and 1% protease inhibitor cocktail. The supernatant was
collected and same amounts of proteins were mixed with loading
buffer, and heated at 95◦C for 10 min before loading onto
10% SDS-polyacrylamide gel. The separated proteins were then
transferred to a PVDF membrane (GE Healthcare, Milwaukee,
WI, USA), and the membrane was blocked with 5% non-fat milk
for 1 h at room temperature. Then, the membrane was probed
with an appropriate primary antibody overnight at 4◦C. After
washing three times with PBT, the membrane was incubated
with HRP-conjugated secondary antibody for 1 h at room
temperature before visualization with the ECL Prime Western
blotting detection system. Antibodies were listed in Table 2.
Image analysis was performed by using a Fujifilm luminescent
image analyzer (Fujifilm Life Science, Stamford, CT, USA).
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FIGURE 4 | Bakuchiol induced alteration in cell cycle and cell cycle regulator expression in breast cancer cells. (A,B) Cells were treated with varying
concentrations of bakuchiol as labeled in the figure for 24 h. (A) Cell cycle analysis with PI staining. (B) Expression levels of P-Cdc2 (Tyr15), Cyclin B1, P-Wee1 (Ser
642), Myt1, p21 (Waf1/Cip1) and β-Actin analyzed with Western blot (C) p21, p53, ATM and ATR mRNA expressions in cells treated with ethanol or 7 µg/ml of
bakuchiol for 24 h. The data represent the mean ± SD of the values from three separate RNA samples (∗p < 0.05, student’s t-test). Ctrl, control; BAK, bakuchol.
Cell Morphology Observation
For the experiment in Figure 7A, MCF-7 cells were seeded on
sterilized cover slide, and treated with 0–10 µg/ml of bakuchiol
for 24 h. After treatment, an inverted microscope (model DMI
3000B, Leica Microsystems, Germany) was used to observe and
record the cell morphology.
Frontiers in Pharmacology | www.frontiersin.org 6 May 2016 | Volume 7 | Article 128
fphar-07-00128 May 21, 2016 Time: 13:40 # 7
Li et al. Phytoestrogen Bakuchiol Inhibits Breast Cancer
FIGURE 5 | Caffeine rescued bakuchiol-induced S phase arrest in breast cancer cells. Cells were treated with ethanol alone or 7 µg/ml of bakuchiol and/or
5 mM of caffeine for 24 h. (A) representative cell cycle histograms from three individual experiments of control and treatment with percentage of cell cycle phase
indicated. (B) Western blot analysis of Chk1, Chk2, P-Cdc2 (Tyr15) in total cell lysates. β-Actin was used as loading control. Ctrl, control; BAK, bakuchiol, CAF,
caffeine.
Zebrafish Xenografts Establishment and
Fish Exposure
Wild-type AB zebrafish embryos were maintained in embryo
medium containing PTU at a 0.003% w/v concentration
to remove the surface pigmentation. For the zebrafish
xenotransplantation, 48 hpf embryos were dechorionated
and anesthetized in and 0.004 w/v tricaine before cell injection.
Before cell injection, cells were labeled with the Green CMFDA
according to manufacturer’s protocol. After staining and
washing, cells were loaded into a pulled glass micropipette and
attached to an air driven microinjector (Eppendorf FentoJet
Express). Approximately 300 cells were injected into the yolk
sac of embryos. After injection, embryos were exposed with
ethanol (solvent control) or 0.5 µg/ml of bakuchiol. The exposed
embryos were maintained for 1 h at 28◦C and then placed
in to incubator at 34◦C for 71 h. Injection was performed
using an Olympus SZX12 dissecting microscope, and the
xenotransplanted embryos were examined by using a Olympus
BX61 flurescence microscope. The integrated fluorescence
intensity was quantified by image analysis software ImageJ.
All procedures with fish were conducted following the License
to Conduct Experiments approved by the Government of
the Hong Kong SAR Department of Health [Ref. (15–10) in
DH/HA&P/8/2/5 Pt.3].
Statistical Analysis
Statistical analyses were conducted by using the SPSS 13.0
program. Experiments were carried out three times and the data
are presented as mean values ± standard deviation. Student’s
t-test, one sample t-test and one-way ANOVA were used to
analyze the data. A p-value of <0.05 is considered to be
statistically significant.
RESULTS
Bakuchiol Exhibits In Vivo Estrogenic
Activity
Bakuchiol induced GFP expression in the liver of the fish
(Figure 2A), and LC50 and EC50 (indicated by GFP induction) of
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FIGURE 6 | Knock-down of p21 marginally rescued the bakuchiol-induced S phase arrest. MCF-7 cells were transfected with siCtrl or sip21, and treated
with 0 or 7 µg/ml of bakuchiol for 24 h. (A) Cell viability was monitored by MTT assay. The data are expressed as fold change of cell viability with standard deviation
(ns p > 0.05, student’s t-test). (B) Cell cycle distribution was studied with PI staining. (C) Fold change of cell number in S phase (∗p < 0.05, student’s t-test).
(D) Western blot analysis of p21, Chk1, Chk2, P-Cdc2 (Tyr15) in total cell lysates. β-Actin was used as loading control. Ctrl, control; BAK, bakuchiol.
bakuchiol were 1.1 and 0.3 µg/ml respectively (Figure 2B). The
signal intensity of the induced GFP increased in a concentration-
dependent manner (Figure 2C). Phytoestrogen usually has weak
estrogenic activity. To make the screening results comparable
with strong estrogenic compound, the dose-dependent response
of transgenic larvae was analyzed with E2 (Figure 2D). The
GFP signal intensity induced by bakuchiol was compared with
the result of the E2 exposure. The GFP intensity of the EC50
(0.3 µg/ml) of bakuchiol was comparable to the estrogenicity
of 1.6 ppb (∼1.6 µg/l) E2. The results suggested that bakuchiol
is a weak estrogen; about 180 times weaker than E2. The
expression levels of the ER α and ERβ of fish after 0.5 µg/ml
bakuchiol treatment were studied with quantitative real-time
PCR. Compared with the control group, both ERα and ERβ
exhibit no significant difference in the bakuchiol treatment group
the trend of upregulation, although there is (Figure 2E), even
GFP expression was induced in 94% of the fish after 0.5 µg/ml
bakuchiol exposure (Figure 2B). Moreover, bakuchiol did not
show a significant preference to either ERα or ERβ in whole fish
(Figure 2E).
Bakuchiol Induces Cell Growth Inhibition
The cell growth of two breast carcinoma cell lines, MCF-7 and
MDA-MB-231, in the presence of various concentrations of
bakuchiol, was examined. In the ERα-positive breast carcinoma
cell line MCF-7, bakuchiol exerted a biphasic effect on the
growth of the cells under the experimental conditions (at 24, 48,
and 72 h) – stimulating cellular proliferation at concentrations
below 2 µg/ml, but inhibiting cell proliferation in a dose-
dependent manner above 2 µg/ml (Figure 3A). IC50 in MCF-
7 cells were 12.1–9.3 µg/ml for 24–72 h exposure. In the
ERα-negative breast cancer cell line MDA-MB-231, bakuchiol
exhibited a marked growth inhibitory effect in dose- and
time-dependent manners (IC50: 13.1–8.9 µg/ml). The IC50
of resveratrol in breast cancer cells were 2.72–4.15 times
of that in bakuchiol (Figure 3B), indicating that bakuchiol
exhibits stronger anti-breast cancer effect. When MCF-7 cells
were co-treated with low dose of bakuchiol (1 µg/ml) and
1 µM ERα antagonist ICI 182780, the proliferative effects
of bakuchiol on ERα-positive cells was blocked (Figure 3C).
The bakuchiol-induced ERα expression was also eliminated
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FIGURE 7 | Bakuchiol induced apoptosis in MCF-7 cells. MCF-7 cells were treated with 0–10 µg/ml of bakuchiol for 24 h. (A) Morphology observation of
bakuchiol treated MCF-7 under bright field. Small apoptotic bodies are labeled with red arrows. The white bar indicates 100 µm. (B) Representative flow cytometry
results of annexin V/PI analysis. (C) JC-1 staining for analysis of mitochondrial membrane potential. Western blot analysis of expression levels of (D) Caspase family
protein, including Cleaved Caspase 7, Cleaved Caspase 9, and Cleaved PARP, and (E) Bcl-2 family protein, including Bak, Bax, and Bim. β-Actin was used as
loading control.
by ICI 182780 (Figure 3C). Upon treated with high doses
(4 and 7 µg/ml) of bakuchiol, the expression levels of ERα
were induced and ERβ were suppressed in MCF-7 cells
(Figure 3D).
Bakuchiol Induces S Phase Arrest and
Expression Level Change of Cell Cycle
Regulator
After the cells were treated for 24 h with increasing
concentrations (0–10 µg/ml) of bakuchiol, a significant
dose-dependent accumulation of cells in S phase in both MCF-7
and MDA-MB-231 (Figure 4A) resulted. We then next examined
the protein levels of cell cycle regulators (Figure 4B). After the
cells were treated with 0–10 µg/ml of bakuchiol, the expression
level of P-Cdc2 (Tyr15) was up-regulated, accompanied with
up-regulation of Myt1 and P-Wee1 (Ser642). In addition,
bakuchiol also induced the upregulation of p21 and Cyclin B1.
The up-regulation of p21 was also confirmed with real-time
PCR (Figure 4C). The ATM mRNA expression levels were
also significantly induced in both MCF-7 and MDA-MB-231
cells (p < 0.05, both, Figure 4C). However, there is only an
upregulated trend of ATR mRNA level, with no significance.
No significant change of p53 mRNA level was observed in both
MCF-7 and MDA-MB-231 cells (Figure 4C).
Caffeine Rescues Bakuchiol-Induced S
Phase Arrest
When the cells were pre-treated with caffeine, a known
ATM/ATR inhibitor, that can inhibits ATM/ATR in MCF-7 and
MDA-MB-231 cells, at the concentration of 5 mM (Yu et al.,
2013), the bakuchiol-induced accumulation of S phase cells was
rescued by caffeine pre-treatment in both MCF-7 and MDA-
MB-231 cells (Figure 5A). The up-regulated expression levels
of P-Cdc2 (Tyr15), Chk1 and Chk2 induced by the bakuchiol
treatment were also rescued by pre-treatment with caffeine
(Figure 5B).
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TABLE 2 | List of antibodies.
Antibody Company Catalog number
P-Cdc2 (Tyr15) Cell Signaling Technology 9111
Cyclin B1 Cell Signaling Technology 4138
P-Wee1 (Ser642) Cell Signaling Technology 4910
Myt1 Cell Signaling Technology 4282
P21 (Waf1/Cip1) Cell Signaling Technology 2947
Chk1 Cell Signaling Technology 2360
Chk2 Cell Signaling Technology 6334
Cleaved Caspase7 Cell Signaling Technology 9491
Cleaved Caspase9 Cell Signaling Technology 9501
Cleaved PARP Cell Signaling Technology 5625
Bak Cell Signaling Technology 6947
Bax Cell Signaling Technology 5023
Bim Cell Signaling Technology 2933
β-Actin Cell Signaling Technology 3700
Anti-rabbit IgG Cell Signaling Technology 7074
Anti-mouse IgG Cell Signaling Technology 7076
Depletion of p21 Marginally Rescues
S-Phase Arrest Caused by Bakuchiol
When MCF-7 cells were transfected with sip21, the expression
level of p21 was down-regulated (Figure 6D). Depletion of p21
marginally rescued bakuchiol-induced inhibitory effect, however,
the difference of cell viability between bauchiol-treated siCtrl
cells and sip21 cells are not significant (p > 0.05, Figure 6A).
In both siCtrl and sip21 transfection cells, bakuchiol induced S
phase arrest (Figure 6B). The level of S phase cell accumulation
was more significant in siCtrl cells than in sip21 cells (p < 0.05,
Figure 6C). Depletion of p21 led to the increased expression
of Chk1 and Chk2 (Figure 6D). The bakuchiol-induced Chk2
expression was more significant in siCtrl cells than in sip21 cells
(p< 0.001, Figure 6D).
Bakuchiol Induces Apoptosis of MCF-7
Cells
Morphological change was observed under inverted microscope
with bright field (Figure 7A). With the bakuchiol concentration
increasing, more of the cells became rounded, shrank and were
unattached. Besides, more small apoptotic bodies broken from
cells can be observed (see red arrow). By using a flow cytometric
analysis after annexin V/PI staining, the effects of bakuchiol
on breast cancer cell apoptosis were determined. Exposure of
MCF-7 cells to bakuchiol elicits a increase in early apoptotic
cells, in a dose-dependent manner (Figure 7B). Besides, flow
cytometric analysis of mitochondrial transmembrane potential
1ψm by using JC-1 staining revealed that bakuchiol reduced
1ψm of MCF-7 cells dose-dependently (Figure 7C). While in
MDA-MB-231 cells, bakuchiol did not affect the cell morphology
and apoptotic rate under the exposure conditions (data not
shown).
The expression levels of Caspase family members and their
substrates were determined with Western blot (Figure 7D). After
24 h of treatment, the expression levels of cleaved Caspase 7,
Caspase 9 and PARP were upregulated by bakuchiol. It has been
demonstrated that Bcl-2 family proteins control mitochondrial
membrane permeabilization, which is essential for apoptotic
regulations. We detected the expression levels of pro-apoptotic
Bcl-2 family proteins (Figure 7E). The levels of Bim-l, Bim-s,
Bak monomers, Bak oligomers and Bax were induced by
bakuchiol.
Bakuchiol Exhibits In Vivo Anti-breast
Cancer Effect
After MCF-7 cells were injected into the yolk sac of 48 hpf
zebrafish embryos, cell mass formation was observed after
72 h (Figure 8A). Compared with control group, bakuchiol
significantly inhibited the cell mass formation, which was
indicated by the integrated fluorescent signal of CMFDA-labeled
cells (p < 0.05, Figure 8B). Importantly, there was no significant
difference in the mortality between control group and treatment
group (p> 0.05, data not shown).
DISCUSSION
Bakuchiol May Act as a SERM and an
Anti-breast Cancer Drug
In current study, bakuchiol exhibits estrogenic activity in both
in vivo and in vitro models. Bakuchiol-induced Chg expression
in the liver of the transgenic medaka fish suggests that bakuchiol
is an ERα agonist in the liver (Chen et al., 2008). When medaka
fish were exposed to 0.5 µg/ml of bakuchiol, GFP expression was
induced in 94% of the fish. However, the increased expressions
of both ERα and ERβ in the whole fish were not significant,
and bakuchiol did not show preference to either ERα or ERβ,
which all suggest that bakuchiol may act as an ER agonist in
some organs and antagonist in other organs in the fish. In
previous studies, bakuchiol exhibited different binding abilities
to ERα and ERβ in different in vitro models, which also implies
that bakuchiol has the role of a SERM (Xin et al., 2010; Lim
et al., 2011). Another two active ingredients of Fructus Psoraleae,
named psoralen and isopsoralen, have also been reported with
in vitro estrogenic activities (Xin et al., 2010; Lim et al., 2011).
However, GFP could not be induced by these two compounds
in transgenic fish in current study (data not shown). The in vivo
estrogenic activity of bakuchiol suggests an advantage over other
phytoestrogens.
In the ERα-positive breast carcinoma cell line MCF-7,
bakuchiol exerts a biphasic effect on the growth of the cells, which
is the stimulating of cellular proliferation at low concentrations
and inhibiting of growth in a dose-dependent manner at
elevated doses. It has been revealed that activation of ERα
could promote breast cancer cell proliferation and breast tumor
growth (Paruthiyil et al., 2004). Our in vitro study confirmed
the estrogenic activity of low dose of bakuchiol. Moreover, the
biphasic effect of bakuchiol on the growth and ERα expression
of MCF-7 cells suggests that bakuchiol is an ERα agonist at low
concentrations and antagonist at high concentrations in breast
tissue. S phase arrest is observed in both bakuchiol-treated breast
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FIGURE 8 | Bakuchiol inhibited in vivo cell mass formation in zebrafish. (A) ∼300 MCF-7 cells were injected into the yolk sac of 48 hpf zebrafish
embryos. 60 embryos were treated with ethanol (solvent control) or 0.5 µg/ml of bakuchiol for 72 h. Triplicates for each condition were performed.
Representative bright field and fluorescent images of embryos in both control and treatment groups showing cell mass in the yolk sac area were shown. The
black and white bars indicate 500 µm. (B) Statistical analysis of integrated fluroscent intensity of cell mass in control and treatment group (∗p < 0.05, one
sample t-test). Ctrl, control; BAK, bakuchiol.
cancer cell lines. However, the level of S phase accumulation in
ERα-positive MCF-7 cells was higher than that in ERα-negative
MDA-MB-231 cells. Besides, bakuchiol only induce apoptosis in
MCF-7 cells, not in MDA-MB-231 cells, which all suggests that
ERα antagonist effect of bakuchiol contributes to the inhibition
of breast cancer cell growth. The bakuchiol-induced ERβ level
may also contribute to the inhibitory effects, since binding to
ERβ may induce heterodimerization with ERα and hence silence
its activation of genes stimulating cell proliferation (Rice and
Whitehead, 2006). The anti-breast cancer effect of bakuchiol was
further proved in the zebrafish MCF-7 cell xenotransplantation
assay. When xenotrasplanted zebrafish embryos were exposed
to 0.5 µg/ml bakuchiol, the cell mass was significantly reduced
without inducing higher mortality.
The breast cancer cell promoting effect is only achieved at the
low concentration of bakuchiol, and the higher concentrations
exhibit opposite effect, which is an advantage over estrogen
used in HRT. However, high dose of phytoestrogens may have
adverse side effects, such as the endocrine disruption of brain
and reproductive track (Patisaul and Jefferson, 2010). It is still
not clear if higher doses of bakuchiol will exhibit positive effect
that overcomes its negative side effect. Thus, bakuchiol may have
the potential to be used in HRT and breast cancer treatment,
based on its in vitro and in vivo estrogenic effect and anti-
breast cancer effect, but further study is necessary to prove its
safety.
Bakuchiol Induces S Phase Arrest in
Breast Cancer Cells Through Inactivation
of Cdc2
Cell cycle entry into mitotic phase is initiated by the
dephosphorylation of two inhibitory residues, Tyr15 and Thr14
of Cdc2, followed by activation of the Cdc2-Cyclin B1 complex
(Zhou and Elledge, 2000). The Wee1 kinase family consists
of Wee1 and Myt1, which can phosphorylate Cdc2 to prevent
cell entry into mitosis. After treatment with bakuchiol, the
expression levels of P-Cdc2 (Tyr15), Myt1 and P-Wee1 (Ser642)
were upregulated in breast cancer cells, thus suggesting that
bakuchiol-induced Cdc2 (Tyr15) phosphorylation may play
a central role in S phase arrest in bakuchiol-treated cells.
Based on current data that bakuchiol induced the expression
of ATM, Chk1 and Chk2, we hypothesized that bakuchiol-
induced S phase arrest is sensed by ATM/ATR. ATM/ATR
are members of the phosphoinositide 3-kinase-related kinase
family that can be activated to phosphorylate on the serine or
threonine residues of their substrates in response to DNA damage
or replication blocks (Abraham, 2004). ATM/ATR activates
Chk1 and Chk2 (Matsuoka et al., 1998), which are known to
phosphorylate Cdc25C at Ser216 in response to DNA damage
(Bulavin et al., 2003). Cdc25C is a dual-specificity protein
kinase that controls mitotic entry by the dephosphorylation
of Cdc2 on both Thr14 and Tyr15 (Coleman and Dunphy,
1994). After pre-treating the cells with 5 mM caffeine, a known
inhibitor of ATM/ATR kinases, the S phase arrest and increasing
expression levels of Chk1 and Chk2 induced by bakuchiol were
abrogated, thus suggesting that ATM/ATR, and Chk1/Chk2 as
upstream regulators, control bakuchiol-induced Cdc2 (Tyr15)
phosphorylation.
In the bakuchiol-induced S phase arrested cells, the p21
expression level was also upregulated. As discussed above,
cell entry mitosis depends on the activation of the Cdc2-
Cyclin B1 complex. It has been shown that p21 blocks the
activation of the Cdc2-Cyclin B1 complex by preventing the
Thr 161 phosphorylation of the Cdc2 subunit (Smits et al.,
2000). The induction of p21 depends on the activation of
Chk1/Chk2, and this induction could be found in both p53
-dependent and -independent manner (Kastan and Bartek, 2004;
Frontiers in Pharmacology | www.frontiersin.org 11 May 2016 | Volume 7 | Article 128
fphar-07-00128 May 21, 2016 Time: 13:40 # 12
Li et al. Phytoestrogen Bakuchiol Inhibits Breast Cancer
Aliouat-Denis et al., 2005). In a negative feedback loop, p21 and
p53 can regulate Chk1/Chk2 negatively (Gottifredi et al., 2001;
Matsui et al., 2004). Thus, the knock-down of p21 only marginally
rescued the bakuchiol-induced S phase arrest.
Both ERα and ERβ can regulate upstream regulators
of Cdc2 activation. ERα downregulates the transcription of
ATM via the activation of miRNAs (Guo et al., 2013). ERα
also blocks ATR/CHK1 signal transduction cascade through
phosphorylation of TopBP1 protein, thus preventing the
enhanced association of ATR with TopBP1 after DNA damage
(Pedram et al., 2009). Furthermore, ERα inhibits the expression
of p21 by up-regulating miR-17 (Liao et al., 2014). ERβ exhibits
opposite effects to ERα. Paruthiyil et al. (2004) reported that ERβ
inhibits cell cycle progression by increasing the expression of p21
in MCF-7 cells. The authors also reported that ERβ inactivates
Cdc2 by inducing it inhibitors, GADD45A and BTG2 (Paruthiyil
et al., 2011). Our results show that high doses of bakuchiol
suppressed the ERαmRNA levels and induced ERβmRNA levels,
suggesting that the ER-mediated inactivation of Cdc2 plays an
important role in bakuchiol-induce S phase arrest.
Bakuchiol Induces Apoptosis in MCF-7
Cells via the Intrinsic Mitochondrial
Pathway
BH3-only proteins-induced activation of Bax/Bak is essential for
mitochondrial-mediated apoptosis. Bim is a BH3-only protein.
All the three splice isoforms of Bim (Bim-s, Bim-l, and Bim-
el) induce apoptosis via binding to Bcl-2 to the mitochondria
to relieve the suppression of Bax/Bak apoptotic effector
oligomerization and pore formation at the outer mitochondrial
membranes (O’Connor et al., 1998). Once Bax/Bak is activated,
cytochrome c is released from mitochondria. In the presence of
cytochrome c and dATP, Caspase-9 and Apaf-1 bind to each other
via their respective NH2-terminal CED-3 homologous domains,
leading to Caspase 9 activation (Li et al., 1997). Caspase 9
propagates the death signal by triggering other caspase activation,
such as Caspase 7 (Slee et al., 1999). Activation of Caspase 7 leads
to the cleavage and inactivation of PARP (Boucher et al., 2012),
thus preventing DNA damage repair.
After treatment with bakuchiol, the expression levels of
Bim-l, Bim-s, Bax, and Bak were up-regulated. Besides that,
Caspase 7, Caspase 9 and PARP were cleaved. The caspase
proteases have been shown to play an important role in the
accomplishment of apoptotic morphology. They can target
proteins which are involved in the formation and regulation
of membrane-associated cortical microfilament cytoskeleton
(Saraste and Pulkki, 2000). They can also target proteins which
are a part of the cell to cell and cell to matrix attachment (Cardone
et al., 1997; Wen et al., 1997). Our results suggested that the
induction of apoptosis and apoptotic body formation caused by
bakuchiol, is likely through intrinsic mitochondrial pathway.
CONCLUSION
In summary, the present study demonstrated that bakuchiol
exhibited both in vitro and in vivo estrogenic activity and
anti-breast cancer effect. Bakuchiol exhibited stronger anti-
proliferative effects in breast cancer cells than its analog
resveratrol. Our data showed that bakuchiol induced S phase
arrest in breast cancer cells through inactivation of Cdc2. In
parallel, apoptosis analysis showed that bakuchiol induced cell
apoptosis via the intrinsic mitochondrial pathway. Our results
show the potential of bakuchiol as an anti-breast cancer drug, as
well as the potential to be used in HRT for relieving menopausal
symptoms, but further study is necessary to prove its efficacy and
safety.
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